Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity.

Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, Döpp ED, Dijkstra CD, Drukarch B, de Vries HE.

J Immunol. 2006 Aug 15;177(4):2630-7.

3.
4.

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.

J Neuroimmunol. 2004 Mar;148(1-2):146-53.

PMID:
14975595
5.
6.

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.

Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A.

Ann Neurol. 2006 Jul;60(1):45-55.

PMID:
16729291
7.

Interferon-beta directly influences monocyte infiltration into the central nervous system.

Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Döpp E, van der Meide PH, Dijkstra CD, De Vries HE.

J Neuroimmunol. 2002 Jun;127(1-2):69-79.

PMID:
12044977
8.

Antioxidant therapy in multiple sclerosis.

Mirshafiey A, Mohsenzadegan M.

Immunopharmacol Immunotoxicol. 2009;31(1):13-29. doi: 10.1080/08923970802331943. Review.

PMID:
18763202
9.

Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.

Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE.

J Exp Med. 2004 Dec 20;200(12):1667-72.

10.

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier.

Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, de Vries HE.

Free Radic Biol Med. 2008 Aug 1;45(3):256-64. doi: 10.1016/j.freeradbiomed.2008.03.024. Epub 2008 Apr 16.

PMID:
18452719
11.

Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.

Li XB, Schluesener HJ.

Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):51-3. Epub 2006 Feb 13.

PMID:
16642257
13.

FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.

Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T.

Brain Pathol. 2009 Apr;19(2):254-66. doi: 10.1111/j.1750-3639.2008.00182.x. Epub 2008 Jun 4.

PMID:
18540945
14.

GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.

Prasad R, Giri S, Nath N, Singh I, Singh AK.

Glia. 2007 Jan 1;55(1):65-77.

PMID:
17019693
15.

Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15511-6. doi: 10.1073/pnas.0807656105. Epub 2008 Sep 30.

16.

Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.

Floris S, Blezer EL, Schreibelt G, Döpp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE.

Brain. 2004 Mar;127(Pt 3):616-27. Epub 2003 Dec 22.

PMID:
14691063
17.

Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation.

Dimitriadou V, Pang X, Theoharides TC.

Int J Immunopharmacol. 2000 Sep;22(9):673-84.

PMID:
10884588
18.
19.

Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier.

Reijerkerk A, Kooij G, van der Pol SM, Leyen T, van Het Hof B, Couraud PO, Vivien D, Dijkstra CD, de Vries HE.

J Immunol. 2008 Sep 1;181(5):3567-74.

20.

Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR.

FASEB J. 2010 Apr;24(4):1023-34. doi: 10.1096/fj.09-141978. Epub 2009 Nov 25.

PMID:
19940258

Supplemental Content

Support Center